Treating today’s cancer patient no longer means simply targeting the cancer. Given the known cardiotoxicities of some established chemotherapies and the possibility that newer approaches may damage the heart, oncologists, cardiologists and imaging specialists now work together to detect and minimize the risk of treatment-induced heart failure.

In a new study conducted at the University of Chicago’s Medical Center, researchers scanned the brains of children between 7 and 11 years old who have moderate or severe obstructive sleep apnea (OSA) and found that, if untreated, it can lead to widespread brain damage.  

Dedicated team resolves multi-vendor workflow issues with vendor neutral services.

A new article published in the Institute for Healthcare Policy & Innovation University of Michigan discusses why patients are unnecessarily tested for rare liver conditions, which raises concerns and costs.

GE Healthcare and Lantheus Medical Imaging have proposed a global deal for a contuniuation of the phase 3 development and global commercialization of Lantheus’s flurpiridaz F 18, a positron emission tomography (PET) myocardial perfusion imaging (MPI) agent for diagnosing coronary artery disease.

New technology employs iterative reconstruction to produce high-quality MR images at a rapid rate with zero diagnostic information loss. 

Last November’s presidential election ended friendships because of opposing political views, and now an MRI study shows why people’s political beliefs just won’t budge.

Thanks to advances in MRI-compatible cardiac device technology, pacemakers and implantable cardioverter defibrillators (ICDs) are no longer absolute contraindications for MRI exams. The devices remain relative contraindications for MRI, however, and their presence in MRI patients calls for radiologists and cardiologists to work closely together in order to both ensure patient safety and minimize legal risk.